Vestal Point Capital’s UroGen Pharma URGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,152,957	Closed	-$23.8M	–	84
2025 Q1	$23.8M	Buy	2,152,957 +522,957	+32%	+$5.78M	1.7%	20
2024 Q4	$17.4M	Buy	1,630,000 +1,230,000	+308%	+$13.1M	1.03%	33
2024 Q3	$5.08M	Buy	+400,000	New	+$5.08M	0.39%	46